FUNCTION OF THE TRANSMEMBRANE DOMAIN OF GLYCOSYLTRANSFERASES
糖基转移酶跨膜域的功能
基本信息
- 批准号:3774327
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Golgi apparatus chimeric proteins complementary DNA enzyme activity fluorescence microscopy galactosyltransferases gene deletion mutation gene expression glycosyltransferase hydropathy intracellular transport membrane proteins molecular cloning nucleic acid sequence polymerase chain reaction posttranslational modifications protein degradation protein signal sequence sialyltransferases tissue /cell culture
项目摘要
Analyses of the cDNA sequences of glycosyltransferases have shown that
these enzymes have inverted membrane topology that consists of a short
amino-terminal cytoplasmic tail, a hydrophobic transmembrane anchor domain
and the carboxyl-terminal catalytic domain. To examine the role of the
transmembrane domain a series of mutants and chimeric cDNA of (beta-1,4-
galactosyltransferase (beta-1,4-GT) were constructed by PCR, transiently
expressed in COS-7 cells, enzyme activities measured and the protein
localized in the cells by subcellular fractionation or indirect
immunofluorescence microscopy. Deletion analyses of the amino-terminal
region show that the first 21 amino acids of beta-1,4-GT are not essential
for the stable production of the protein and are consistently localized in
the Golgi apparatus. However, as reported earlier, the deletion of the
transmembrane domain abolishes the stable expression of this protein in
mammalian cells. In addition, analysis of hybrid constructs showed that
residue 1-25 of alpha-1,3-GT can functionally replace the beta-1,4-GT
amino-terminal cytoplasmic and transmembrane domain (residues 1-43). This
fusion protein also showed Golgi localization. On the other hand, protein
fused to the transmembrane domain of (alpha-2,6-sialyltransferase (alpha-
2,6-ST) needed additional COOH-terminal sequences flanking the domain for
stability and Golgi localization. Substitution of Arg24, Leu25, Leu26 and
His33 of (beta-l,4-GT transmembrane by lIe or substitution of Tyr by Ile
at positions 40 and 41 coupled with the insertion of four lIe at position
43 released the mutant proteins from the Golgi and were detected on the
cell surface. Our results show that a) the transmembrane domains of (beta-
l,4-GT, alpha-1,3-GT, and of alpha-2,6-ST along with its stem region all
play a role in Golgi targeting, and participate in a common mechanism that
allows the protein to be processed properly and not be degraded in vivo;
b) increasing the length of the transmembrane domain overrides the Golgi
retention signal and directs the enzyme to the plasma membrane; and c) the
length of the hydrophobic region of the transmembrane domain is an
important parameter, but is not sufficient by itself for Golgi retention.
糖基转移酶的cDNA序列分析表明,
这些酶具有由短的
氨基末端胞质尾,疏水性跨膜锚结构域
和羧基末端催化结构域。为了研究
跨膜结构域的一系列突变体和嵌合cDNA的(β-1,4-
通过PCR瞬时构建半乳糖基转移酶(β-1,4-GT)
在COS-7细胞中表达,测定酶活性,
通过亚细胞分级分离或间接的
免疫荧光显微术。氨基末端缺失分析
区域显示β-1,4-GT的前21个氨基酸不是必需的
稳定生产蛋白质,并始终定位于
高尔基体。然而,如前所述,
跨膜结构域消除了这种蛋白在细胞中的稳定表达,
哺乳动物细胞此外,杂交构建体的分析显示,
α-1,3-GT的残基1-25可以在功能上取代β-1,4-GT
氨基末端胞质和跨膜结构域(残基1-43)。这
融合蛋白也显示出高尔基体定位。另一方面,蛋白质
融合到(α-2,6-唾液酸转移酶(α-
2,6-ST)需要额外的COOH-末端序列侧翼的结构域,
稳定性和高尔基体定位。Arg 24、Leu 25、Leu 26和Arg 24的取代
β-l,4-GT跨膜的His 33被IIe取代或Tyr被IIe取代
在位置40和41处,
43从高尔基体释放突变蛋白,并在
细胞表面我们的研究结果表明:a)(β-
1,4-GT、α-1,3-GT和α-2,6-ST沿着及其茎区的所有
在高尔基体定位中发挥作用,并参与一种共同的机制,
允许蛋白质被适当地加工并且在体内不被降解;
B)增加跨膜结构域的长度覆盖高尔基体
保留信号并将酶引导至质膜;和
跨膜结构域的疏水区的长度是
重要参数,但本身不足以保持高尔基体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
P K QASBA其他文献
P K QASBA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('P K QASBA', 18)}}的其他基金
CRYSTALLIZATION AND 3D STRUCTURE DETERMINATION OF B-1,4GALACTOSYLTRANSFERASE
B-1,4 半乳糖基转移酶的结晶和 3D 结构测定
- 批准号:
2463784 - 财政年份:
- 资助金额:
-- - 项目类别:
FUNCTIONAL ANALYSIS OF THE CATALYTIC DOMAIN OF BETA-1,4GALACTOSYLTRANSFERASE
β-1,4半乳糖基转移酶催化域的功能分析
- 批准号:
2463740 - 财政年份:
- 资助金额:
-- - 项目类别:
MD SIMULATIONS OF THE TRANSMEMBRANE REGION OF GOLGI GLYCOSYLTRANSFERASES
高尔基体糖基转移酶跨膜区的 MD 模拟
- 批准号:
2463834 - 财政年份:
- 资助金额:
-- - 项目类别:
ESSENTIALITY OF INSULIN FOR THE ACCUMULATION OF RAT MILK PROTEIN MRNA'S
胰岛素对于大鼠乳蛋白 mRNA 积累的重要性
- 批准号:
4691827 - 财政年份:
- 资助金额:
-- - 项目类别:
3D STRUCTURE DETERMINATION OF RECOMBINANT BETA-1-GALACTOSYLTRANSFERASEFERASE
重组 β-1-半乳糖基转移酶的 3D 结构测定
- 批准号:
6100974 - 财政年份:
- 资助金额:
-- - 项目类别:
CONFORMATIONAL AND PROTEIN BINDING ANALYSIS OF OLIGOSACCHARIDES
低聚糖的构象和蛋白质结合分析
- 批准号:
3752042 - 财政年份:
- 资助金额:
-- - 项目类别:
PRIMARY STRUCTURE AND TOPOLOGY OF BETA 1-4 GALATOSYLTRANSFERASE
Beta 1-4 半乳糖基转移酶的一级结构和拓扑结构
- 批准号:
3916335 - 财政年份:
- 资助金额:
-- - 项目类别:
CONFORMATIONAL AND PROTEIN BINDING ANALYSIS OF OLIGOSACCHARIDES
低聚糖的构象和蛋白质结合分析
- 批准号:
3774329 - 财政年份:
- 资助金额:
-- - 项目类别:
EXPRESSION OF BETA 1-4 GALACTOSYLTRANSFERASE IN GROWING 3TC CELLS
生长中的 3TC 细胞中 β 1-4 半乳糖基转移酶的表达
- 批准号:
3813371 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
- 批准号:
10448505 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
- 批准号:
10312411 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Increasing efficiency in formation of chimeric proteins
提高嵌合蛋白形成的效率
- 批准号:
561998-2021 - 财政年份:2021
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Decoration and Dimerization of Chimeric Proteins Mediated by Coiled-Coil Interactions
卷曲螺旋相互作用介导的嵌合蛋白的修饰和二聚化
- 批准号:
537306-2018 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Collaborative Research and Development Grants
Exploring the therapeutic potential of chimeric proteins
探索嵌合蛋白的治疗潜力
- 批准号:
1947736 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Studentship
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
靶向蛋白质相互作用并设计嵌合蛋白质
- 批准号:
8364271 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Therapeutic peanut allergen Fc gamma chimeric proteins to treat peanut allergy
用于治疗花生过敏的治疗性花生过敏原 Fc γ 嵌合蛋白
- 批准号:
8444422 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Cat allergen-human Fc-gamma1 chimeric proteins to treat cat allergy
猫过敏原-人Fc-gamma1嵌合蛋白治疗猫过敏
- 批准号:
7907314 - 财政年份:2010
- 资助金额:
-- - 项目类别:
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
靶向蛋白质相互作用并设计嵌合蛋白质
- 批准号:
8171849 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Therapeutic peanut allergen Fc gamma chimeric proteins to treat peanut allergy
用于治疗花生过敏的治疗性花生过敏原 Fc γ 嵌合蛋白
- 批准号:
8313432 - 财政年份:2010
- 资助金额:
-- - 项目类别: